Bioporto As Stock Analysis

BioPorto Pink Sheet Analysis Notes

About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. BioPorto A/S had not issued any dividends in recent years. BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.The quote for BioPorto AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about BioPorto AS contact the company at 45 45 29 00 00 or learn more at https://bioporto.com.

BioPorto A/S Investment Alerts

BioPorto Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 121.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto A/S's market, we take the total number of its shares issued and multiply it by BioPorto A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

BioPorto Profitablity

The company has Profit Margin (PM) of (2.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.82.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BioPorto A/S prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioPorto shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BioPorto A/S. By using and applying BioPorto Pink Sheet analysis, traders can create a robust methodology for identifying BioPorto entry and exit points for their positions.

When running BioPorto A/S's price analysis, check to measure BioPorto A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPorto A/S is operating at the current time. Most of BioPorto A/S's value examination focuses on studying past and present price action to predict the probability of BioPorto A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPorto A/S's price. Additionally, you may evaluate how the addition of BioPorto A/S to your portfolios can decrease your overall portfolio volatility.